Asio Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Buy
56,189
+3,172
+6% +$182K 0.41% 70
2026
Q1
$3.22M Buy
+53,017
New +$3.09M 0.45% 62
2023
Q3
Sell
-4,562
Closed -$292K 98
2023
Q2
$292K Hold
4,562
0.07% 96
2023
Q1
$316K Hold
4,562
0.08% 92
2022
Q4
$328K Hold
4,562
0.09% 91
2022
Q3
$324K Hold
4,562
0.1% 93
2022
Q2
$351K Hold
4,562
0.11% 91
2022
Q1
$333K Sell
4,562
-300
-6% -$20.1K 0.09% 96
2021
Q4
$303K Sell
4,862
-53,932
-92% -$3.16M 0.09% 90
2021
Q3
$3.48M Buy
58,794
+1,402
+2% +$92.3K 1.2% 28
2021
Q2
$3.83M Sell
57,392
-1,446
-2% -$94.3K 1.35% 26
2021
Q1
$3.71M Buy
58,838
+20,363
+53% +$1.27M 1.54% 20
2020
Q4
$2.39M Buy
38,475
+7,667
+25% +$471K 1.15% 41
2020
Q3
$1.86M Buy
30,808
+4,515
+17% +$272K 1.02% 48
2020
Q2
$1.55M Buy
+26,293
New +$1.57M 0.98% 53
2020
Q1
Sell
-30
Closed -$1 88
2019
Q4
$1 Buy
+30
New +$1.72K ﹤0.01% 186

Other funds holding BMY

Asio Capital's BMY Position: Q2 2026 in Review

Asio Capital increased its Bristol-Myers Squibb (BMY) stake by 6% in Q2 2026, buying an estimated $182K and bringing the position to 56,189 shares worth $3.24M. The position accounts for 0.41% of the portfolio, ranked #70.

Asio Capital first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $3.83M in Q2 2021. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Asio Capital held 56,189 shares of Bristol-Myers Squibb worth $3.24M as of Q2 2026.
  • Asio Capital bought 3,172 Bristol-Myers Squibb shares in Q2 2026, an estimated $182K.
  • Bristol-Myers Squibb made up 0.41% of Asio Capital's portfolio in Q2 2026, its #70 holding.
  • Asio Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
  • Asio Capital's Bristol-Myers Squibb position peaked at $3.83M in Q2 2021.
  • 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Asio Capital's 13F filing for Q2 2026, filed 17 Jul 2026.